Effects of opioids on proximal renal tubular cells undergoing ATP depletion

Luca Bellini1, Marta Vadori2, Giulia Maria De Benedictis3

  • 1Department of Animal Medicine, Production and Health, University of Padua, Viale dell'Università 16, 30128, Padua, Legnaro, Italy.

Insights

Morphine, fentanyl, and butorphanol may protect kidney cells from damage during ischemia. These opioids reduced cell death and caspase activity following anoxic injury, suggesting potential therapeutic benefits in kidney injury.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Opioid analgesics are widely used, but their effects on kidney cells, particularly during ischemic events, require further investigation.
  • Renal proximal tubular cells are crucial for kidney function and are vulnerable to ischemic damage.
  • Understanding opioid-induced cellular responses is vital for managing patients with kidney conditions.

Purpose of the Study:

  • To evaluate the impact of morphine, fentanyl, butorphanol, and buprenorphine on renal proximal tubular cell viability and apoptosis.
  • To determine if pre- or post-treatment with these opioids influences cell response to chemical anoxia.
  • To explore potential protective mechanisms of opioids against kidney ischemia-reperfusion injury.

Main Methods:

  • Renal proximal tubular cells were exposed to morphine, fentanyl, butorphanol, or buprenorphine.
  • Cells were subsequently subjected to chemical anoxia for a defined period.
  • Cell viability, intracellular ATP content, and caspase-3 activity were measured to assess cellular injury and apoptosis.

Main Results:

  • Cell viability decreased across all treatment groups, but intracellular ATP levels increased with morphine and fentanyl pre-treatment.
  • Anoxia significantly elevated caspase-3 activity, indicative of apoptosis.
  • Morphine, fentanyl, and butorphanol treatments (pre- or post-anoxia) significantly reduced the anoxia-induced increase in caspase-3 activity.
  • Buprenorphine showed no significant effect on cell viability or caspase-3 activity.

Conclusions:

  • Morphine, fentanyl, and butorphanol may exert protective effects against renal ischemic injury by modulating apoptosis.
  • These findings suggest a potential role for specific opioids in mitigating kidney damage during ischemia.
  • Further research is warranted to elucidate the precise mechanisms and clinical applicability of these protective effects.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.7K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.4K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.0K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.3K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1.0K